RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+10.05%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$630M
AUM Growth
+$630M
(+12%)
Cap. Flow
+$14.3M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
120
New
23
Increased
22
Reduced
39
Closed
13
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 2 |
Merck
MRK
|
$12.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$12.4M |
| 4 |
AGN
Allergan plc
AGN
|
$6.33M |
| 5 |
UnitedHealth
UNH
|
$6.3M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$20M |
| 2 |
Pfizer
PFE
|
$13.2M |
| 3 |
Medtronic
MDT
|
$11M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$8.04M |
| 5 |
CPHD
Cepheid Inc
CPHD
|
$8M |
Sector Composition
| 1 | Healthcare | 86.01% |
| 2 | Financials | 0.83% |
| 3 | Technology | 0.09% |
| 4 | Energy | 0.06% |
| 5 | Industrials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
JPMorgan Chase
JPM
$824B
| $179K | 0.03% |
+2,688
| New | +$179K |
|
102
Ford
F
$46.2B
| $176K | 0.03% |
+14,611
| New | +$176K |
|
|
MTEM
103
DELISTED
Molecular Templates, Inc.
MTEM
| $137K | 0.02% |
201,537
| – | – |
|
|
MDVN
104
DELISTED
MEDIVATION, INC.
MDVN
| – | – |
-80,000
| Closed | -$4.82M |
|
|
CPHD
105
DELISTED
Cepheid Inc
CPHD
| – | – |
-260,000
| Closed | -$8M |
|
|
QHC
106
DELISTED
Quorum Health Corporation
QHC
| – | – |
-56,250
| Closed | -$602K |
|
|
CERN
107
DELISTED
Cerner Corp
CERN
| – | – |
-81,000
| Closed | -$4.75M |
|
108
Ultragenyx Pharmaceutical
RARE
$3.04B
| – | – |
-10,000
| Closed | -$489K |
|
|
109
Pfizer
PFE
$141B
| – | – |
-375,000
| Closed | -$13.2M |
|
|
110
Medtronic
MDT
$118B
| – | – |
-127,000
| Closed | -$11M |
|
111
LivaNova
LIVN
$3.09B
| – | – |
-70,000
| Closed | -$3.52M |
|
|
112
Gilead Sciences
GILD
$140B
| – | – |
-240,000
| Closed | -$20M |
|
113
Elevance Health
ELV
$72.4B
| – | – |
-40,000
| Closed | -$5.25M |
|
114
Community Health Systems
CYH
$392M
| – | – |
-175,000
| Closed | -$2.11M |
|
115
Becton Dickinson
BDX
$54.3B
| – | – |
-15,000
| Closed | -$2.54M |
|
116
Abbott
ABT
$230B
| – | – |
-84,100
| Closed | -$3.31M |
|